Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jami Mandelin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|March 16, 2005
Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formationJami Mandelin, Mikko Liljeström, Tian-Fang Li, et al.
Molecular Cancer Therapeutics|May 2, 2022
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against CancersMaija Hollmén, Mikael Maksimow, Jenna H Rannikko, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2023
Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practiceKrista Heinolainen, Silva Saarinen, Simona Vertuani, et al.
Plos One|January 22, 2013
Circadian timekeeping is disturbed in rheumatoid arthritis at molecular levelVesa-Petteri Kouri, Juri Olkkonen, Emilia Kaivosoja, et al.
The Journal of Experimental Medicine|August 20, 2003
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic featuresJuha Paloneva, Jami Mandelin, Anna Kiialainen, et al.
Rheumatology (Oxford, England)|July 6, 2022
IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via IκBζ-dependent induction of ELF3Vesa-Petteri Kouri, Juri Olkkonen, Katariina Nurmi, et al.
Scientific Reports|May 14, 2025
CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignanciesSofia Aakko, Arno Ylitalo, Heikki Kuusanmäki, et al.
The Journal of Rheumatology|September 11, 2003
Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prosthesesJami Mandelin, Tian-Fang Li, Mika V J Hukkanen, et al.
Bone|December 13, 2005
Human osteoblasts produce cathepsin KJami Mandelin, Mika Hukkanen, Tian-Fang Li, et al.
Arthritis and Rheumatism|April 16, 2002
Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritisYrjö T Konttinen, Jami Mandelin, Tian-Fang Li, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|March 16, 2005
Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formationJami Mandelin, Mikko Liljeström, Tian-Fang Li, et al.
Molecular Cancer Therapeutics|May 2, 2022
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against CancersMaija Hollmén, Mikael Maksimow, Jenna H Rannikko, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2023
Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practiceKrista Heinolainen, Silva Saarinen, Simona Vertuani, et al.
Plos One|January 22, 2013
Circadian timekeeping is disturbed in rheumatoid arthritis at molecular levelVesa-Petteri Kouri, Juri Olkkonen, Emilia Kaivosoja, et al.
The Journal of Experimental Medicine|August 20, 2003
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic featuresJuha Paloneva, Jami Mandelin, Anna Kiialainen, et al.
Rheumatology (Oxford, England)|July 6, 2022
IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via IκBζ-dependent induction of ELF3Vesa-Petteri Kouri, Juri Olkkonen, Katariina Nurmi, et al.
Scientific Reports|May 14, 2025
CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignanciesSofia Aakko, Arno Ylitalo, Heikki Kuusanmäki, et al.
The Journal of Rheumatology|September 11, 2003
Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prosthesesJami Mandelin, Tian-Fang Li, Mika V J Hukkanen, et al.
Bone|December 13, 2005
Human osteoblasts produce cathepsin KJami Mandelin, Mika Hukkanen, Tian-Fang Li, et al.
Arthritis and Rheumatism|April 16, 2002
Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritisYrjö T Konttinen, Jami Mandelin, Tian-Fang Li, et al.
Pageof 3